(Q43758864)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Rita Romani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Cinzia Antognelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

A Lanari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

V Gallai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

L Parnetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

Mechanisms of Ageing and Development

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

2057-2062

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

Clinical benefits of a new piperidine-class AChE inhibitor

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Butyrylcholinesterase in the life cycle of amyloid plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

Rivastigmine. A review of its use in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900314-1

7 January 2021

10.1016/S0047-6374(01)00314-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11589922%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference